Alpha Dna Investment Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Alpha Dna Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $452,173 - $578,035	33,297 New	33,297 $523,000
Q2 2021 Aug 10, 2021	SELL	$32.73 - $47.95 $98 - $143	-3 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$40.39 - $56.73 $472,199 - $663,230	-11,691 Reduced 99.97%	3 $0
Q4 2020 Mar 24, 2021	SELL	$51.77 - $66.18 $61,606 - $78,754	-1,190 Reduced 9.24%	11,694 $667,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $667,004 - $852,663	12,884 New	12,884 $735,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.